The stable overexpression of SPRYD7 was able to induce angiogenesis, especially in the poorly metastatic cells, whereas the transient depletion of SPRYD7 reduced the angiogenesis capacity of CRC cells. This evidence concerns the gene SPRYD7 and colorectal carcinoma.